Close Menu

NanoString

NEW YORK (GenomeWeb News) – Shares of Sequenom dropped more than 28 percent in the July, making it the biggest mover among firms in the GenomeWeb Daily News Index during the month.

NanoString Technologies this week announced the availability of nCounter Elements, general purpose reagents developed for translational research and clinical laboratories.

NEW YORK (GenomeWeb News) – Investment bank Leerink Swann on Sunday initiated coverage of newly public NanoString Technologies with an Outperform rating and a $15 price target on its stock.

Originally published July 9.

NEW YORK (GenomeWeb News) – NanoString Technologies late on Tuesday priced its planned initial public offering at $10 per share.

NEW YORK (GenomeWeb News) – NanoString Technologies today said that it anticipates raising as much as $77.6 million in its initial public offering.

NEW YORK (GenomeWeb News) – Translational life science tools and molecular diagnostics company NanoString Technologies today filed for an initial public offering.

NEW YORK (GenomeWeb News) – NanoString Technologies today announced it has secured the option to exclusively license a 186-gene signature from the Broad Institute that may be useful in determining the prognosis of patients diagnosed with hepatocellular carcinoma, or HCC.

NanoString Technologies of Seattle has received US Patent No.

NanoString Technologies has appointed Gary Riordan as VP of quality and regulatory affairs and Kathy Surace-Smith as VP and general counsel.

Pages

A study of families explores how children transmit SARS-CoV-2, according to the Associated Press.

US Agricultural Research Service scientists have sequenced the genome of the Asian giant hornet.

According to the Economist, pooled testing for COVID-19 could help alleviate strains on testing labs.

In Science this week: MIT researchers outline approach dubbed translatable components regression to predict treatment response among IBD patients.